Sovenyr Get early access

Signal2026-07-21

PubMed

NOD1/2 signaling in macrophages drives adaptive immune resistance in cancer.

Part of

Emerging Cancer Biomarker Techniques

Open primary source See the whole picture

Powered by Sovenyr — cross-source signal intelligence. Figures are collected data as-dated, not investment advice.